Director Global Medical Affairs Oncology Biomarker & CDx (m/f/x)

Apply now »

Date: 12-May-2022

Location: All Europe, Europe, 81379

Company: Daiichi Sankyo Europe


Passion for Innovation. Compassion for Patients.


Daiichi Sankyo and its 16,000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In Europe, we focus on two areas: In the cardiovascular space, our strong portfolio of medicines reflects our long-standing commitment and shows that we care for every heartbeat; in oncology our goal is to become a global pharma innovator until 2025 by providing novel therapies to patients across the world. Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries. For more information:


For our Global Medical Affairs Oncology Team (GOMA)  team located in the US (DSI) and in EU (DSE), we are looking for an

Director Global Medical Affairs Oncology Biomarker & CDx (m/f/x)

The position:

The Director Global Medical Affairs Oncology (GOMA), Biomarkers & Companion Diagnostics (CDx) is a dedicated GOMA expert to partner with the GOMA Team Lead and cross-functional stakeholders in development of and input into GOMA, clinical development, commercial, and market access strategic imperatives related to biomarker and CDx within the Oncology Therapeutic Area. The role also drives development and execution of GOMA tactics related to Biomarker and CDx to support the assigned compound portfolio and business strategies.


Roles and responsibilities:

Evidence generation 

  • Serve as a strategic partner to GOMAT Lead/TA Directors in development of and driving execution of the GOMA Plan to support the overall portfolio and business strategies related to evidence generation, medical information and internal education, publications, scientific exchange and external data communication, and stakeholder scientific engagement
  • Serve as biomarker and CDx lead for select company-sponsored GOMA evidence generating studies/projects and drives execution for assigned projects in collaboration with GOMA Clinical Operations and other cross-functional and regional stakeholders
  • Serve as a member of the GOMA Evidence Generation Team
  • Support review of investigator-initiated studies (IIS) and serve as deputy compound lead in Global IIS Review Committee meetings


Medical strategic planning and implementation 

  • Drive the development of GOMA strategies and tactics for assigned compound indications related to Biomarkers and CDx
  • Active contributor and member of the Global Medical Affairs Team (GOMAT) to ensure alignment of global medical and cross functional strategies
  • Gains strategic and planning alignment across regions and functions and supports review of local country/regional medical affairs activities related to biomarker and CDx when applicable
  • Provide input and support for related strategies and initiatives of the R&D clinical development and Biomarker/CDx, Commercial and Market Access plans
  • Drive Biomarker and CDx medical readiness activities for market launches and life cycle management


Scientific education, communication, and engagement 

  • Establish and maintain internal and external relationships, and represent GOMA in stakeholder engagements to facilitate medical input and activities
  • Serve as an expert in biomarkers and companion diagnostics, including information from scientific journals and congresses, to alert GOMAT and other relevant stakeholders of critical new information that may affect strategies/plans
  • Provide scientific & medical education to medical affairs staff, and other team members related to, biomarker, diagnostic and disease-specific information
  • Engage with key external experts, including oncologists, scientists, pathologists to identify relevant gaps and areas to be addressed in support of medical and market launch initiatives, including questions and topics to be addressed by Field Medical Affairs, Scientific Exchange, Congress Medical Information, and other relevant aspects, etc.


Develop and implement a responsible budget stewardship 

  • Develop and effectively manage annual operating plan and budget for the biomarker and CDx team


Personal skills and professional experience:

  • Advanced degree in scientific discipline (e.g., Masters, PhD, PharmD, MD)
  • 7+ years of relevant experience in pharma; minimum of 3 years of medical affairs experience, global preferred. Oncology experience highly desirable
  • Previous overall responsibility and accountability for multiple indications of one or more compounds and related GOMA plan/budget for related MA activities
  • Demonstrated ability to lead and influence others internally and externally
  • Experience leading matrix medical teams (e.g. GOMAT) and representing medical on cross-functional leadership teams (e.g. Global Product Team, Global Brand Team, etc.)
  • Relationships with key opinion leaders
  • Immunohistochemistry (IHC) and/or next generation sequencing (NGS)
  • Biomarker and diagnosis, including CDx and liquid biopsy
  • Molecular and/or anatomical pathology
  • Diagnostic/Testing landscape and SOC of common cancers including breast cancer, NSCLC, gastric and colorectal cancer
  • Excellent written and oral communication skills, particularly strong formal presentation skills
  • Strong interpersonal skills commensurate with the need to work closely with both outside physicians/ scientists/pathologists and numerous in-house support groups
  • Demonstrated high proficiency in problem solving ability and possession of strong scientific analytical skills
  • Excellent planning and organizational skills; experience in setting and adhering to departmental budgets
  • Knowledge of scientific methods, research design and medical and diagnostic practices and procedures that would be acquired through clinical experience and clinical research studies
  • Ability to travel up to 30%



What we offer

Working at Daiichi Sankyo

At Daiichi Sankyo in Europe, we offer a workplace where your voice is heard. Everything we do, we do with a high level of commitment and a clear focus on patients’ needs. We know that our bold ambition to change patients’ lives for the better can only be achieved through the power of collaboration and the exploration of new approaches. Thus, we encourage our colleagues across Europe to be courageous, to bring their ideas to the table and to embrace opportunities to grow. When you join our European family, you will be a part of a dynamic company where everyone, no matter their role, rolls up their sleeves and gets things done.